FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates

Since 21 October, the US Food and Drug Administration (FDA) has been on a tear in approving five new drugs (all with list prices of more than $100,000 per year) months ahead of when they were expected to be approved.